Bioasis Technologies Past Earnings Performance
Past criteria checks 0/6
There is insufficient data on Bioasis Technologies's performance over the last few years.
Key information
n/a
Earnings growth rate
n/a
EPS growth rate
| Biotechs Industry Growth | 51.1% |
| Revenue growth rate | n/a |
| Return on equity | n/a |
| Net Margin | n/a |
| Last Earnings Update | 30 Nov 2022 |
Recent past performance updates
In this section we usually display a company’s past earnings and revenues to help investors visualise the trend through time. We also gauge the company’s performance by benchmarking its returns and growth to its industry peers and the wider market. However, Bioasis Technologies has not provided sufficient past data to assess its track record.
This is quite a rare situation as 97% of companies covered by Simply Wall St do have historical data.
Show sectionRevenue & Expenses Breakdown
How Bioasis Technologies makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Nov 22 | 0 | -3 | 2 | 0 |
| 31 Aug 22 | 0 | -3 | 2 | 0 |
| 31 May 22 | 0 | -3 | 2 | 0 |
| 28 Feb 22 | 0 | -3 | 2 | 0 |
| 30 Nov 21 | 0 | -3 | 2 | 0 |
| 31 Aug 21 | 0 | -1 | 2 | -1 |
| 31 May 21 | 4 | 1 | 2 | 0 |
| 28 Feb 21 | 4 | 1 | 2 | 0 |
| 30 Nov 20 | 4 | 1 | 2 | 0 |
| 31 Aug 20 | 4 | 0 | 2 | 1 |
| 31 May 20 | 0 | -4 | 2 | 2 |
| 29 Feb 20 | 1 | -4 | 3 | 2 |
| 30 Nov 19 | 1 | -4 | 4 | 2 |
| 31 Aug 19 | 2 | -4 | 4 | 2 |
| 31 May 19 | 2 | -3 | 5 | 2 |
| 28 Feb 19 | 1 | -3 | 4 | 2 |
| 30 Nov 18 | 1 | -5 | 5 | 2 |
| 31 Aug 18 | 0 | -6 | 5 | 2 |
| 31 May 18 | 0 | -6 | 5 | 1 |
| 28 Feb 18 | 1 | -5 | 4 | 1 |
| 30 Nov 17 | 1 | -3 | 3 | 1 |
| 31 Aug 17 | 1 | -3 | 2 | 1 |
| 31 May 17 | 1 | -3 | 2 | 1 |
| 28 Feb 17 | 1 | -3 | 2 | 1 |
| 30 Nov 16 | 1 | -3 | 2 | 1 |
| 31 Aug 16 | 0 | -3 | 2 | 1 |
| 31 May 16 | 1 | -3 | 2 | 1 |
| 29 Feb 16 | 0 | -3 | 2 | 1 |
| 30 Nov 15 | 0 | -3 | 2 | 1 |
| 31 Aug 15 | 0 | -3 | 2 | 1 |
| 31 May 15 | 0 | -3 | 2 | 1 |
| 28 Feb 15 | 0 | -3 | 1 | 1 |
| 30 Nov 14 | 0 | -3 | 2 | 2 |
| 31 Aug 14 | 0 | -4 | 2 | 2 |
| 31 May 14 | 0 | -4 | 2 | 2 |
| 28 Feb 14 | 0 | -4 | 2 | 2 |
| 30 Nov 13 | 0 | -4 | 2 | 2 |
Quality Earnings: Insufficient data to determine if BTI.H has high quality earnings.
Growing Profit Margin: Insufficient data to determine if BTI.H's profit margins have improved over the past year.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: Insufficient data to determine if BTI.H's year-on-year earnings growth rate was positive over the past 5 years.
Accelerating Growth: Insufficient data to compare BTI.H's past year earnings growth to its 5-year average.
Earnings vs Industry: Insufficient data to determine if BTI.H's earnings growth over the past year exceeded the Biotechs industry average.
Return on Equity
High ROE: BTI.H has a negative Return on Equity (0%), as it is currently unprofitable.